Kura Oncology (KURA) Retained Earnings: 2024-2025
Historic Retained Earnings for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to -$1.1 billion.
- Kura Oncology's Retained Earnings fell 24.75% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 24.75%. This contributed to the annual value of -$895.4 million for FY2024, which is N/A change from last year.
- As of Q3 2025, Kura Oncology's Retained Earnings stood at -$1.1 billion, which was down 7.27% from -$1.0 billion recorded in Q2 2025.
- In the past 5 years, Kura Oncology's Retained Earnings registered a high of -$771.0 million during Q1 2024, and its lowest value of -$1.1 billion during Q3 2025.
- For the 2-year period, Kura Oncology's Retained Earnings averaged around -$918.5 million, with its median value being -$895.4 million (2024).
- Data for Kura Oncology's Retained Earnings shows a maximum YoY decreased of 24.75% (in 2025) over the last 5 years.
- Kura Oncology's Retained Earnings (Quarterly) stood at -$895.4 million in 2024, then fell by 24.75% to -$1.1 billion in 2025.
- Its last three reported values are -$1.1 billion in Q3 2025, -$1.0 billion for Q2 2025, and -$952.9 million during Q1 2025.